GLP-1s avoid anti-doping listing

Athletes are being warned to be "very careful" when using GLP-1s by the World Anti-Doping Agency (WADA), with the organisation to continue monitoring them in 2027  Ozempic (semaglutide) and Mounjaro (tirzepatide) will remain on the WADA's "monitoring list" in 2027, after the organisation decided against prohibiting their use by athletes.   Speaking after the release of